Skin-in-the-game companies outperform

Nassim Taleb says skin in the game is a moral imperative

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A new report by Macquarie Equities has found that companies with directors that have shares in the company generally outperform by more than 8%.

That's something that we here at the Motley Fool have known for a long time. Directors tend to be more motivated to look after their shareholders when they have a significant stake in the company, given they will share in the costs and benefits of their decisions.

In a pleasing sign, Suncorp (ASX: SUN) announced last month that its directors would need to own more than $200,000 of the company's stock. That could see a new trend start where shareholders push for directors to hold more shares in the companies they manage. We would like to see the trend take off, as owning shares in the company they manage makes directors more aligned with their shareholders. Suncorp has given its directors four years to comply with the policy.

The report also found that companies with directors with skin in the game tend to generate higher returns on equity. Higher returns on equity can be an indication of a company outperforming its peers.

Companies with directors with very few shares tend to underperform and that has been proven time and time again. There have been plenty of companies where directors get paid millions and underperform their peers and the market. In some cases companies have paid their directors bonuses despite meagre returns to shareholders and even negative returns. Shareholders have rightly decried directors' remuneration in those cases, but it's more a case of shutting the barn door after the horse has bolted.

So far this year a few companies have attracted first strikes from shareholders over their remuneration reports, including David Jones (ASX: DJS), iSelect (ASX: ISU), Aurizon (ASX: AZJ) and SCA Property Trust (ASX: SCP).

Foolish takeaway

Nassim Taleb, author of The Black Swan and Fooled by Randomness, says skin in the game is not just good policy but a moral imperative. Foolish investors may want to consider checking on directors' shareholdings when looking at companies to invest in.

Motley Fool writer/analyst Mike King doesn’t own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »